Search Results - "Toussirot, É."

Des spondylarthropathies aux spondyloarthrites : vers une nouvelle dénomination pour un diagnostic précoce et de nouvelles indications thérapeutiques ? by Toussirot, É.

Get full text

High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies by DROUART, M., SAAS, P., BILLOT, M., CEDOZ, J.‐P., TIBERGHIEN, P., WENDLING, D., TOUSSIROT, É.

“…SUMMARY Angiogenesis is involved in chronic inflammatory joint diseases such as rheumatoid arthritis (RA). Vascular endothelial growth factor (VEGF) plays a…”
Get full text

Adiponectin in autoimmune diseases by Toussirot, É, Binda, D, Gueugnon, C, Dumoulin, G

“…Adiponectin is the most abundant adipokine circulating in the organism. Different molecular forms of adiponectin exist: low, middle and high molecular…”
Get more information

From spondyloarthropathies to spondyloarthritis: towards a new terminology for an early diagnosis and new therapeutic interventions? by Toussirot, É

Get full text

New‐onset vitiligo and progression of pre‐existing vitiligo during treatment with biological agents in chronic inflammatory diseases by Méry‐Bossard, L., Bagny, K., Chaby, G., Khemis, A., Maccari, F., Marotte, H., Perrot, J.L., Reguiai, Z., Sigal, M.L., Avenel‐Audran, M., Boyé, T., Grasland, A., Gillard, J., Jullien, D., Toussirot, E.

“…Background The development of vitiligo during treatment with biological agents is an unusual event and only a few isolated cases have been reported. Objectives…”
Get full text

Développement d’un vitiligo au cours du traitement d’une spondylarthrite ankylosante par adalimumab by Toussirot, É., Salard, D., Algros, M.-P., Aubin, F.

Get full text

Agents anti-TNFα et sarcoïdose by TOUSSIROT, E, PERTUISET, E

“…Le TNFα est impliqué dans la physiopathologie de la sarcoïdose du fait de la forte production de TNFα par les macrophages alvéolaires et du rôle de cette…”
Get full text

Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry by Godot, S., Gottenberg, J.‐E., Paternotte, S., Pane, I., Combe, B., Sibilia, J., Flipo, R.‐M., Schaeverbeke, T., Ravaud, P., Toussirot, E., Berenbaum, F., Mariette, X., Wendling, D., Sellam, J.

“…Objective We used data from the AutoImmunity and Rituximab (AIR) registry to investigate the safety of surgery for patients with rheumatoid arthritis receiving…”
Get full text

Eighteen cases of crowned dens syndrome: Presentation and diagnosis by Godfrin-Valnet, M, Godfrin, G, Godard, J, Prati, C, Toussirot, E, Michel, F, Wendling, D

“…Abstract Background and purpose Crowned dens syndrome is an ill-known etiology of acute neck pain. Methods We carried out a retrospective study of 18 cases of…”
Get full text

TNFα blocking agents and sarcoidosis: an update by Toussirot, E, Pertuiset, E

“…Increased production of TNFα by alveolar macrophages and involvement of TNFα in granuloma formation suggest that this cytokine is involved in the…”
Get full text

Sarcoidosis occuring during anti-TNF-α treatment for inflammatory rheumatic diseases : report of two cases by TOUSSIROT, E, PERTUISET, E, KANTELIP, B, WENDLING, D

“…Anti-TNF-alpha agents have been tried in cases of refractory sarcoidosis, giving favourable results. Thus, the occurrence of a granulomatous disease in a…”
Get full text

The piriformis muscle syndrome: An exploration of anatomical context, pathophysiological hypotheses and diagnostic criteria by Michel, F, Decavel, P, Toussirot, E, Tatu, L, Aleton, E, Monnier, G, Garbuio, P, Parratte, B

“…Abstract Introduction The piriformis muscle syndrome (PMS) has remained an ill-defined entity. It is a form of entrapment neuropathy involving compression of…”
Get full text

Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis by Toussirot, Éric, Wendling, Daniel

“…PURPOSE OF REVIEWBisphosphonates are antiosteoclastic agents widely used in the treatment of bone diseases. They also have antiinflammatory properties…”
Get full text

Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy by Wendling, D, Auge, B, Bettinger, D, Lohse, A, Le Huede, G, Bresson-Hadni, S, Toussirot, E, Miguet, J-P, Herbein, G, Di Martino, V

“…[...]our patient was an asymptomatic HBV carrier, without any increase in serum ALT recorded over a long follow up period. [...]although she received…”
Get full text

Relationship between growth hormone–IGF-I–IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis by Toussirot, É., Nguyen, N. U., Dumoulin, G., Aubin, F., Cédoz, J.-P., Wendling, D.

“…Objectives. Hormonal factors playing a role in bone mass and body composition have been rarely assessed in rheumatoid arthritis (RA). In this study, we aimed…”
Get full text

Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials [Corrigendum] by Toussirot, Eric, Vauchy, Charline, Binda, Delphine, Michel, Fabrice

“…Toussirot E, Vauchy C, Binda D, Michel F. Drug Des Devel Ther. 2016;10:2087-2094.On page 2089, a column heading in Table 1 was incorrectly presented. The last…”
Get full text

Bone density, ultrasound measurements and body composition in early ankylosing spondylitis by Toussirot, E., Michel, F., Wendling, D.

“…Objectives. In this cross‐sectional study, we evaluated bone density using both dual‐energy X‐ray absorptiometry (DEXA) and quantitative ultrasound (QUS)…”
Get full text

Characteristics and survival of 26 patients with paraneoplastic arthritis by Morel, J, Deschamps, V, Toussirot, E, Pertuiset, E, Sordet, C, Kieffer, P, Berthelot, J M, Champagne, H, Mariette, X, Combe, B

“…To date, only a few series of patients with paraneoplastic arthritis have been published. The charts of patients with cancer-associated arthritis were…”
Get more information

Association spondyloarthrite et maladies inflammatoires chroniques de l’intestin : des atteintes plus sévères des 2 côtés by Michel, J., Prati, C., Vuitton, L., Vauchy, C., Toussirot, É., Mauny, F., Chouk, M., Fakih, O., Wendling, D., Verhoeven, F.

Get full text

Response to “Comment on ‘Piriformis muscle syndrome: Diagnostic criteria and treatment of a monocentric series of 250 patients”’ by F. Michel et al by Michel, F, Decavel, P, Toussirot, E, Tatu, L, Aleton, E, Nollet, S, Garbuio, P, Parratte, B

Get full text